CMV pneumonitis primary prevention

Revision as of 14:25, 1 February 2012 by Michael Maddaleni (talk | contribs) (Created page with "{{CMG}} {{CMV pneumonitis}} ==Overview== The following have been shown to help prevent CMV pneumonia in certain patients: *Using organ transplant donors who don't have CMV. ...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

CMV pneumonitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating CMV pneumonitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

CMV pneumonitis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of CMV pneumonitis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on CMV pneumonitis primary prevention

CDC on CMV pneumonitis primary prevention

CMV pneumonitis primary prevention in the news

Blogs on CMV pneumonitis primary prevention

Directions to Hospitals Treating CMV pneumonitis

Risk calculators and risk factors for CMV pneumonitis primary prevention

Overview

The following have been shown to help prevent CMV pneumonia in certain patients:

  • Using organ transplant donors who don't have CMV.
  • Using CMV-negative blood products for transfusion.
  • Using CMV-immune globulin in certain patients.

Preventing AIDS avoids opportunistic diseases, including CMV, that can occur in people who have a damaged or poorly functioning immune system. People with AIDS who have a CD4 count of less than 100 should consider taking preventive treatment for CMV.

References